Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture

Authors

Huimin Yan, Washington University School of Medicine in St. Louis
Ying Hu, Washington University School of Medicine in St. Louis
Antonina Akk, Washington University School of Medicine in St. Louis
Samuel A Wickline, University of South Florida
Hua Pan, Washington University School of Medicine in St. Louis
Christine T N Pham, Washington University School of Medicine in St. Louis

Journal

Biomaterials Advances

Publication Date

8-1-2022

Volume

139

First Page

213009

Document Type

Open Access Publication

DOI

10.1016/j.bioadv.2022.213009

Rights and Permissions

Yan H, Hu Y, Akk A, Wickline SA, Pan H, Pham CTN. Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture. Biomater Adv. 2022 Aug;139:213009. doi: 10.1016/j.bioadv.2022.213009. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Yan, Huimin; Hu, Ying; Akk, Antonina; Wickline, Samuel A; Pan, Hua; and Pham, Christine T N, "Peptide-siRNA nanoparticles targeting NF-κB p50 mitigate experimental abdominal aortic aneurysm progression and rupture." Biomaterials Advances. 139, 213009 (2022).
https://digitalcommons.wustl.edu/oa_4/3759

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.